Can you imagine a situation where six ace stock pickers, Rakesh Jhunjhunwala, Ramesh Damani, Raamdeo Agrawal, Sanjoy Bhattacharyya, Bharat Shah and Sukumar Rajah set out their favourite stocks and give detailed justification for the same?
Posts in category Mid Cap
IPCA Is At Ridiculous Levels + Other Stock Picks Of Devang Mehta Of Anand Rathi
Devang Mehta Of Anand Rathi has revealed his favourite stocks in an interview to ET
Va Tech Wabag Has Gallons of Opportunity. Take A Sip Of It: Sharekhan
Sharekhan has issued a research report claiming that Va Tech Wabag has “gallons of opportunity” and that investors should buy the stock for huge upside
Top Large-Cap & Mid-Cap Stocks To Buy Now
Prabhudas Liladhar has issued a research report recommending investment in 12 large-cap and 6 mid-cap stocks which they claim have the potential to give good gains to investors
Saurabh Mukherjea Shocks With Contra Sell Call On LIC Housing Finance Even As Daljeet Kohli Puts A Buy On It
When two ace stock pickers take diametrically opposite views about a stock, it puts us in a precarious position. We need to stay alert to the situation and take appropriate action
After Rakesh Jhunjhunwala, Mohnish Pabrai & Basant Maheshwari, Even UBS Is Bullish About Housing Finance Stocks
All savvy investors are making a bee-line for stocks of housing finance companies on the basis that they will be the beneficiaries of dual factors of NAMO’s 100-cities push and the interest rate cuts. UBS has provided valuable guidance on why these stocks will shine
Akash Prakash Of Amansa Capital Joins Ace Value Investor, Sankaran Naren, In Buying Truckload Of Gateway Distriparks
Gateway Distriparks is likely to be one of the big beneficiaries of the GST. Ace investors like Sankaran Naren and Akash Prakash are busy buying truckloads of the stock. We need to stay alert to the situation
Take Advantage Of Russian Crises To Buy JB Chem For 50% Gain: Daljeet Kohli
JB Chem has been battered due to the currency crises in Russia. This presents an opportunity for us to tuck into this fundamentally strong Pharma company says Daljeet Kohli
Aurobindo Pharma Has Immense Potential To Grow: Sharekhan
Sharekhan has issued a research report claiming that the the acquisition of Natrol is a positive development for Aurobindo Pharma and that the stock should be bought
Cash In On Gains From Gulf Oil Lubricants: Sharekhan
Sharekhan has issued a report advising investors to book part profits from the huge run up in Gulf Oil Lubricants
Recent Comments